126 related articles for article (PubMed ID: 31425727)
1. Data derived Extrapolation Factors for developmental toxicity: A preliminary research case study with perfluorooctanoate (PFOA).
Dourson ML; Gadagbui B; Onyema C; McGinnis PM; York RG
Regul Toxicol Pharmacol; 2019 Nov; 108():104446. PubMed ID: 31425727
[TBL] [Abstract][Full Text] [Related]
2. Incorporation of fetal and child PFOA dosimetry in the derivation of health-based toxicity values.
Kieskamp KK; Worley RR; McLanahan ED; Verner MA
Environ Int; 2018 Feb; 111():260-267. PubMed ID: 29325971
[TBL] [Abstract][Full Text] [Related]
3. Analysis for data-derived extrapolation factors for procymidone.
Gadagbui BK; York RG; Dourson ML; McGinnis PM; Cope RB
Regul Toxicol Pharmacol; 2021 Aug; 124():104972. PubMed ID: 34119600
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric anchoring of in vivo and in vitro studies for perfluorooctanoate and perfluorooctanesulfonate.
Wambaugh JF; Setzer RW; Pitruzzello AM; Liu J; Reif DM; Kleinstreuer NC; Wang NC; Sipes N; Martin M; Das K; DeWitt JC; Strynar M; Judson R; Houck KA; Lau C
Toxicol Sci; 2013 Dec; 136(2):308-27. PubMed ID: 24046276
[TBL] [Abstract][Full Text] [Related]
5. Maternal exposure causes mitochondrial dysfunction in brain, liver, and heart of mouse fetus: An explanation for perfluorooctanoic acid induced abortion and developmental toxicity.
Salimi A; Nikoosiar Jahromi M; Pourahmad J
Environ Toxicol; 2019 Jul; 34(7):878-885. PubMed ID: 31037826
[TBL] [Abstract][Full Text] [Related]
6. Physiologically based pharmacokinetic modeling of human exposure to perfluorooctanoic acid suggests historical non drinking-water exposures are important for predicting current serum concentrations.
Worley RR; Yang X; Fisher J
Toxicol Appl Pharmacol; 2017 Sep; 330():9-21. PubMed ID: 28684146
[TBL] [Abstract][Full Text] [Related]
7. Perflurooctanoic acid induces developmental cardiotoxicity in chicken embryos and hatchlings.
Jiang Q; Lust RM; Strynar MJ; Dagnino S; DeWitt JC
Toxicology; 2012 Mar; 293(1-3):97-106. PubMed ID: 22273728
[TBL] [Abstract][Full Text] [Related]
8. Toxicokinetics of perfluorooctanoate (PFOA) in rainbow trout (Oncorhynchus mykiss).
Consoer DM; Hoffman AD; Fitzsimmons PN; Kosian PA; Nichols JW
Aquat Toxicol; 2014 Nov; 156():65-73. PubMed ID: 25150511
[TBL] [Abstract][Full Text] [Related]
9. Effects of perfluorooctanoic acid (PFOA) on expression of peroxisome proliferator-activated receptors (PPAR) and nuclear receptor-regulated genes in fetal and postnatal CD-1 mouse tissues.
Abbott BD; Wood CR; Watkins AM; Tatum-Gibbs K; Das KP; Lau C
Reprod Toxicol; 2012 Jul; 33(4):491-505. PubMed ID: 22154759
[TBL] [Abstract][Full Text] [Related]
10. Tissue distribution of
Bogdanska J; Borg D; Bergström U; Mellring M; Bergman Å; DePierre J; Nobel S
Chemosphere; 2020 Jan; 239():124755. PubMed ID: 31726523
[TBL] [Abstract][Full Text] [Related]
11. Analysis of PFOA in dosed CD1 mice. Part 1. Methods development for the analysis of tissues and fluids from pregnant and lactating mice and their pups.
Reiner JL; Nakayama SF; Delinsky AD; Stanko JP; Fenton SE; Lindstrom AB; Strynar MJ
Reprod Toxicol; 2009 Jun; 27(3-4):360-364. PubMed ID: 19028561
[TBL] [Abstract][Full Text] [Related]
12. Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals.
Kudo N; Kawashima Y
J Toxicol Sci; 2003 May; 28(2):49-57. PubMed ID: 12820537
[TBL] [Abstract][Full Text] [Related]
13. Effects of developmental exposure to perfluorooctanoic acid (PFOA) on long bone morphology and bone cell differentiation.
Koskela A; Finnilä MA; Korkalainen M; Spulber S; Koponen J; Håkansson H; Tuukkanen J; Viluksela M
Toxicol Appl Pharmacol; 2016 Jun; 301():14-21. PubMed ID: 27068293
[TBL] [Abstract][Full Text] [Related]
14. The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice.
Li X; Wang Z; Klaunig JE
Toxicology; 2019 Mar; 416():1-14. PubMed ID: 30711707
[TBL] [Abstract][Full Text] [Related]
15. In utero exposure to perfluorooctanoate (PFOA) or perfluorooctane sulfonate (PFOS) did not increase body weight or intestinal tumorigenesis in multiple intestinal neoplasia (Min/+) mice.
Ngo HT; Hetland RB; Sabaredzovic A; Haug LS; Steffensen IL
Environ Res; 2014 Jul; 132():251-63. PubMed ID: 24834819
[TBL] [Abstract][Full Text] [Related]
16. High-dose, short-term exposure of mice to perfluorooctanesulfonate (PFOS) or perfluorooctanoate (PFOA) affects the number of circulating neutrophils differently, but enhances the inflammatory responses of macrophages to lipopolysaccharide (LPS) in a similar fashion.
Qazi MR; Bogdanska J; Butenhoff JL; Nelson BD; DePierre JW; Abedi-Valugerdi M
Toxicology; 2009 Aug; 262(3):207-14. PubMed ID: 19540903
[TBL] [Abstract][Full Text] [Related]
17. Prenatal exposure to perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS) and maternally reported developmental milestones in infancy.
Fei C; McLaughlin JK; Lipworth L; Olsen J
Environ Health Perspect; 2008 Oct; 116(10):1391-5. PubMed ID: 18941583
[TBL] [Abstract][Full Text] [Related]
18. The mammary gland is a sensitive pubertal target in CD-1 and C57Bl/6 mice following perinatal perfluorooctanoic acid (PFOA) exposure.
Tucker DK; Macon MB; Strynar MJ; Dagnino S; Andersen E; Fenton SE
Reprod Toxicol; 2015 Jul; 54():26-36. PubMed ID: 25499722
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of placental and lactational pharmacokinetics of PFOA and PFOS in the pregnant, lactating, fetal and neonatal rat using a physiologically based pharmacokinetic model.
Loccisano AE; Campbell JL; Butenhoff JL; Andersen ME; Clewell HJ
Reprod Toxicol; 2012 Jul; 33(4):468-490. PubMed ID: 21872655
[TBL] [Abstract][Full Text] [Related]
20. Differential toxicity between perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA).
Tsuda S
J Toxicol Sci; 2016; 41(Special):SP27-SP36. PubMed ID: 28003637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
